Anti- @entity3391 XXXX : clinical characteristics, predictors of outcome and the knowledge gap in southwest China.

@entity1 @entity410 @entity198 @entity11627 @entity146 @entity5 @entity11410 @entity3391 @entity909 @entity716 @entity2414
BACKGROUND AND PURPOSE: The aim was to analyse the clinical profiles and outcomes of patients with anti- @entity3391 receptor (anti-NMDAR) @entity198 in China. METHODS: A retrospective study of anti-NMDAR @entity198 in China was performed between June 2011 and June 2014. The clinical characteristics and predictors of poor outcome were determined. RESULTS: A total of 51 @entity1 with a definitive diagnosis of anti-NMDAR @entity198 were included in this study. Four of them were surgically confirmed to have a @entity5 . Thirty-two @entity1 , amongst whom 24 were female, presented with @entity146 as the initial symptom, whereas 14 @entity1 , of whom nine were male, presented with @entity410 as the initial symptom (P = 0.011). Twenty-nine @entity1 (56.86%) were initially misdiagnosed with @entity716 , @entity11410 or other diseases, and 58.8% of the @entity1 experienced at least one type of complication. It typically took 3 weeks before these @entity1 were admitted to our hospital and another 2 weeks before the correct diagnosis was made. Forty-one @entity1 (80%) reached a good outcome; 10 @entity1 (20%) had a poor outcome. Older age, extended hospital stay, @entity2414 , @entity909 , @entity11627 , complications and abnormal cerebrospinal fluid results were associated with poor outcome (P < 0.05). CONCLUSIONS: Female @entity1 more frequently initially present with @entity146 but male @entity1 more frequently initially present with @entity410 . Patients with anti-NMDAR @entity198 in China have a lower incidence of @entity5 . Nevertheless, this study reveals several challenges in treating anti-NMDAR @entity198 in China that may contribute to poor outcome.
